DK572281A - Nye derivater af antiflogistisk virksomme carbonsyrer deres fremstilling og medicinske anvendelse - Google Patents

Nye derivater af antiflogistisk virksomme carbonsyrer deres fremstilling og medicinske anvendelse

Info

Publication number
DK572281A
DK572281A DK572281A DK572281A DK572281A DK 572281 A DK572281 A DK 572281A DK 572281 A DK572281 A DK 572281A DK 572281 A DK572281 A DK 572281A DK 572281 A DK572281 A DK 572281A
Authority
DK
Denmark
Prior art keywords
antiflogistically
manufacturing
medical use
new derivatives
effective carbon
Prior art date
Application number
DK572281A
Other languages
English (en)
Inventor
H Vorbrueggen
I Boettcher
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK572281A publication Critical patent/DK572281A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/12Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/081,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK572281A 1980-12-23 1981-12-22 Nye derivater af antiflogistisk virksomme carbonsyrer deres fremstilling og medicinske anvendelse DK572281A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803049405 DE3049405A1 (de) 1980-12-23 1980-12-23 Neue derivate von antiphlogistisch wirksamen carbonsaeuren, ihre herstellung und medizinische anwendung

Publications (1)

Publication Number Publication Date
DK572281A true DK572281A (da) 1982-06-24

Family

ID=6120496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK572281A DK572281A (da) 1980-12-23 1981-12-22 Nye derivater af antiflogistisk virksomme carbonsyrer deres fremstilling og medicinske anvendelse

Country Status (7)

Country Link
US (1) US4391814A (da)
EP (1) EP0054812A1 (da)
JP (1) JPS57167977A (da)
AU (1) AU7873781A (da)
DE (1) DE3049405A1 (da)
DK (1) DK572281A (da)
GB (1) GB2091251A (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206885A1 (de) * 1982-02-26 1983-09-15 Troponwerke GmbH & Co KG, 5000 Köln Indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な1,2,4−オキサジアゾ−ル誘導体
ATE29494T1 (de) * 1983-08-11 1987-09-15 Synthelabo Indol-derivate, verfahren zu deren herstellung und deren therapeutische anwendung.
FR2621486B1 (fr) * 1987-10-07 1990-01-26 Synthelabo Utilisation de derives de pyrrolo(3,2,1-hi)indole pour obtenir un medicament destine au traitement du diabete
KR910005851B1 (ko) * 1983-12-12 1991-08-05 신 떼라보 피롤로[3,2,1-hi]인돌유도체 및 약학적으로 허용되는 그의 산부가염을 제조하는 방법
DE3411868A1 (de) * 1984-03-30 1985-10-10 The Dow Chemical Co., Midland, Mich. Herstellung in fluessiger phase von 2-h-2-oxazolinen und 2-substituierten 2-oxazolinen mit einem anorganischen zinksalz
US5262540A (en) * 1989-12-20 1993-11-16 Bristol-Myers Squibb Company [2(4,5-diaryl-2 oxazoyl substituted phenoxy alkanoic acid and esters
US5266702A (en) * 1990-09-19 1993-11-30 Council Of Scientific & Industrial Research 1,3-oxazoline compounds useful as anionic initiators suitable for polymerization of vinyl polymers
US5223521A (en) * 1991-03-08 1993-06-29 Brigham And Women's Hospital Pyrazole and thiozole derivatives for treatment of gastrointestinal ulcer disease
US5811425A (en) * 1997-03-04 1998-09-22 Abbott Laboratories Heterocyclic compounds as COX-2 inhibitors
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
TW200301698A (en) 2001-12-21 2003-07-16 Bristol Myers Squibb Co Acridone inhibitors of IMPDH enzyme
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617618B2 (de) * 1966-06-18 1976-05-20 Merck Patent Gmbh, 6100 Darmstadt Schleimhautabschwellende mittel zur lokalen applikation
IL37850A (en) * 1970-10-19 1973-11-28 Robins Co Inc A H 2-(p-phenylbenzyl)-oxazolines,their preparation and pharmaceutical compositions containing them
GB1400448A (en) * 1971-08-25 1975-07-16 Boots Co Ltd Oxazoline derivatives arylalkanoic acids their preparation and therapeutic compositions containing them
US3726893A (en) * 1971-09-09 1973-04-10 Robins Co Inc A H 2-(p-phenylbenzyl)oxazolines
GB1396726A (en) * 1972-06-15 1975-06-04 Boots Co Ltd Phenylalkanoic acids
JPS51141835A (en) * 1975-05-28 1976-12-07 Teikoku Chem Ind Corp Ltd Process for preparing phenylacetic acid derivatives.
JPS5223058A (en) * 1975-08-15 1977-02-21 Sankyo Co Ltd Preparation of indanylpropionic acid derivatives
JPS5481260A (en) * 1977-11-21 1979-06-28 Toyama Chem Co Ltd 2-4-(3-methyl-2-thienyl)phenyl propionic acid, its nontoxic salt and antiphlogistics, analgesics, and antirheumatics containing them
IL56484A0 (en) * 1978-01-25 1979-03-12 Ciba Geigy Ag Novel phenoxyalkyloxazolines, their preparation and their use as herbicides
DE2830141A1 (de) * 1978-07-08 1980-01-17 Hoechst Ag Neue verbindungen aus der gruppe der phenoxypropionsaeuren bzw. ihrer derivate und diese verbindungen enthaltende herbizide mittel

Also Published As

Publication number Publication date
US4391814A (en) 1983-07-05
AU7873781A (en) 1982-07-01
GB2091251A (en) 1982-07-28
EP0054812A1 (de) 1982-06-30
JPS57167977A (en) 1982-10-16
DE3049405A1 (de) 1982-07-15

Similar Documents

Publication Publication Date Title
DK242578A (da) Tetrahydrofuranderivater deres fremstilling og anvendelse
DK103581A (da) Heterocycliske forbindelser deres fremstilling og anvendelse
DK22679A (da) Substituerede propanolamin og morpholinderivater og fremgangsmaade til fremstilling deraf
DK579078A (da) Optisk aktive forbindelser deres fremstilling og anvendelse
DK445978A (da) Chromanderivater deres fremstilling og anvendelsesom insecticider og acaricider
DK363080A (da) Clavulansyresalte og anvendelse deraf
NO822439L (no) Nye bicykliske pyrimidin-5-on-derivater og fremgangsmaate for deres fremstilling
DK283479A (da) 1-(3-mercapto-2-methylpropanoyl)-prolyl-aminosyre-derivater deres fremstilling og anvendelse
DK572281A (da) Nye derivater af antiflogistisk virksomme carbonsyrer deres fremstilling og medicinske anvendelse
NO823083L (no) Bisestere av alkenylravsyrer og etylenoksyd-propylenoksyd-blokkpolymerisater og deres anvendelse
DK315979A (da) Indanylderivater deres fremstilling og anvendelse
NO790626L (no) Nye antigenderivater og fremgangsmaate til deres fremstilling
DK538277A (da) Derivater af thiazolidinacarboxylsyrer og dermed beslaegtede syrer
TR20880A (tr) Akrilonitrilin aritilmasi
NO803076L (no) Alkyletere av polyoler, fremgangsmaate og anvendelse derav
DK483481A (da) Enkephalinderivater og farmaceutisk acceptable salte deraf deres fremstilling og anvendelse
DK59379A (da) Stabiliserede azulminsyrer deres fremstilling og anvendelse
NO802027L (no) Nye substituerte heterocykliske fenoksyaminer og fremgangsmaate til deres fremstilling
DK298881A (da) Isoxazolylimidazolidinonderivater deres fremstilling og anvendelse som herbicider
DK263180A (da) Fremgangsmaade til fremstilling af substituerede 2-nitro-5-phenoxy-benzosyrer og salte deraf
DK155380A (da) Distyrylbiphenyler deres fremstilling og anvendelse
NO802889L (no) 2-amino-4-substituerte-thiazolcarboxylsyrer og derivater derav
DK58379A (da) Phenoxypropionsyrederivater deres fremstilling og anvendelse
DK286580A (da) Thiazolinderivater deres fremstilling og anvendelse
DK581181A (da) Thiazolinderivater deres fremstilling og anvendelse